Novel Coronavirus (SARS-CoV-2/COVID-19)
Health care systems face difficult challenges in their effort to provide safe and effective care not just for COVID-19 patients, but all patients living with serious illness.
Shelter-in-place orders and the closure of restaurants, bars and entertainment-related businesses helped to slow the spread of COVID-19 between March 1 and April 27, according to a study published by Health Affairs.
The Food and Drug Administration authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.
Based on early data, the Abbott ID NOW point-of-care test to diagnose COVID-19 may return false negative results, the Food and Drug Administration announced, adding that it will continue to review data as the company conducts post-market studies to better understand the cause.
The CDC issued a health advisory warning of COVID-19-associated multisystem inflammatory syndrome in children.
CMS recently issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans.
The AHA urged the nation's primary federal regulators for insured depository institutions to prepare to take prompt action to assist health care providers on the front line of the COVID-19 pandemic should the need to do so arise.
The CDC will award $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, localities and territories by May 23 to expand COVID-19 testing and surveillance activities, the agency announced.
The Centers for Medicare & Medicaid Services issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans. Please see the CMS information bulletin to state Medicaid agencies for details.
The Department of Health and Human Services (HHS) yesterday announced that the next deadline for submitting data to inform the agency’s distribution of its supply of remdesivir is Monday, May 18 at 11:59 p.m. ET.